These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Performance Characteristics of BinaxNOW COVID-19 Antigen Card for Screening Asymptomatic Individuals in a University Setting. Okoye NC; Barker AP; Curtis K; Orlandi RR; Snavely EA; Wright C; Hanson KE; Pearson LN J Clin Microbiol; 2021 Mar; 59(4):. PubMed ID: 33509809 [TBL] [Abstract][Full Text] [Related]
3. Comparison of Severe Acute Respiratory Syndrome Coronavirus 2 Screening Using Reverse Transcriptase-Quantitative Polymerase Chain Reaction or CRISPR-Based Assays in Asymptomatic College Students. Rauch JN; Valois E; Ponce-Rojas JC; Aralis Z; Lach RS; Zappa F; Audouard M; Solley SC; Vaidya C; Costello M; Smith H; Javanbakht A; Malear B; Polito L; Comer S; Arn K; Kosik KS; Acosta-Alvear D; Wilson MZ; Fitzgibbons L; Arias C JAMA Netw Open; 2021 Feb; 4(2):e2037129. PubMed ID: 33570576 [TBL] [Abstract][Full Text] [Related]
4. Effectiveness of Abbott BinaxNOW Rapid Antigen Test for Detection of SARS-CoV-2 Infections in Outbreak among Horse Racetrack Workers, California, USA. Surasi K; Cummings KJ; Hanson C; Morris MK; Salas M; Seftel D; Ortiz L; Thilakaratne R; Stainken C; Wadford DA Emerg Infect Dis; 2021 Nov; 27(11):2761-2767. PubMed ID: 34469287 [TBL] [Abstract][Full Text] [Related]
5. Analytical Sensitivity of the Abbott BinaxNOW COVID-19 Ag Card. Perchetti GA; Huang ML; Mills MG; Jerome KR; Greninger AL J Clin Microbiol; 2021 Feb; 59(3):. PubMed ID: 33310764 [TBL] [Abstract][Full Text] [Related]
6. Performance Characteristics of the Abbott BinaxNOW SARS-CoV-2 Antigen Test in Comparison to Real-Time Reverse Transcriptase PCR and Viral Culture in Community Testing Sites during November 2020. Almendares O; Prince-Guerra JL; Nolen LD; Gunn JKL; Dale AP; Buono SA; Deutsch-Feldman M; Suppiah S; Hao L; Zeng Y; Stevens VA; Knipe K; Pompey J; Atherstone C; Bui DP; Powell T; Tamin A; Harcourt JL; Petway M; Bohannon C; Folster JM; MacNeil A; Salerno R; Kuhnert-Tallman W; Tate JE; Thornburg N; Kirking HL; Sheiban K; Kudrna J; Cullen T; Komatsu KK; Villanueva JM; Rose DA; Neatherlin JC; Anderson M; Rota PA; Honein MA; Bower WA; J Clin Microbiol; 2022 Jan; 60(1):e0174221. PubMed ID: 34705535 [TBL] [Abstract][Full Text] [Related]
7. Assessment of SARS-CoV-2 Screening Strategies to Permit the Safe Reopening of College Campuses in the United States. Paltiel AD; Zheng A; Walensky RP JAMA Netw Open; 2020 Jul; 3(7):e2016818. PubMed ID: 32735339 [TBL] [Abstract][Full Text] [Related]
9. Performance of the BinaxNOW coronavirus disease 2019 (COVID-19) Antigen Card test relative to the severe acute respiratory coronavirus virus 2 (SARS-CoV-2) real-time reverse transcriptase polymerase chain reaction (rRT-PCR) assay among symptomatic and asymptomatic healthcare employees. James AE; Gulley T; Kothari A; Holder K; Garner K; Patil N Infect Control Hosp Epidemiol; 2022 Jan; 43(1):99-101. PubMed ID: 33487197 [TBL] [Abstract][Full Text] [Related]
10. A Real-World Comparison of SARS-CoV-2 Rapid Antigen Testing versus PCR Testing in Florida. Allan-Blitz LT; Klausner JD J Clin Microbiol; 2021 Sep; 59(10):e0110721. PubMed ID: 34346715 [TBL] [Abstract][Full Text] [Related]
11. Performance of Repeat BinaxNOW Severe Acute Respiratory Syndrome Coronavirus 2 Antigen Testing in a Community Setting, Wisconsin, November 2020-December 2020. Shah MM; Salvatore PP; Ford L; Kamitani E; Whaley MJ; Mitchell K; Currie DW; Morgan CN; Segaloff HE; Lecher S; Somers T; Van Dyke ME; Bigouette JP; Delaney A; DaSilva J; O'Hegarty M; Boyle-Estheimer L; Abdirizak F; Karpathy SE; Meece J; Ivanic L; Goffard K; Gieryn D; Sterkel A; Bateman A; Kahrs J; Langolf K; Zochert T; Knight NW; Hsu CH; Kirking HL; Tate JE Clin Infect Dis; 2021 Jul; 73(Suppl 1):S54-S57. PubMed ID: 33909068 [TBL] [Abstract][Full Text] [Related]
12. Human and novel coronavirus infections in children: a review. Rajapakse N; Dixit D Paediatr Int Child Health; 2021 Feb; 41(1):36-55. PubMed ID: 32584199 [TBL] [Abstract][Full Text] [Related]
13. Multiplex Real-Time Reverse Transcription PCR for Influenza A Virus, Influenza B Virus, and Severe Acute Respiratory Syndrome Coronavirus 2. Shu B; Kirby MK; Davis WG; Warnes C; Liddell J; Liu J; Wu KH; Hassell N; Benitez AJ; Wilson MM; Keller MW; Rambo-Martin BL; Camara Y; Winter J; Kondor RJ; Zhou B; Spies S; Rose LE; Winchell JM; Limbago BM; Wentworth DE; Barnes JR Emerg Infect Dis; 2021; 27(7):1821-1830. PubMed ID: 34152951 [TBL] [Abstract][Full Text] [Related]
14. A Cross-Sectional Analysis of Demographic and Behavioral Risk Factors of Severe Acute Respiratory Syndrome Coronavirus 2 Seropositivity Among a Sample of U.S. College Students. Kianersi S; Ludema C; Macy JT; Garcia Colato E; Chen C; Luetke M; Lown MH; Rosenberg M J Adolesc Health; 2021 Aug; 69(2):219-226. PubMed ID: 34112598 [TBL] [Abstract][Full Text] [Related]
15. Reverse Transcription Recombinase-Aided Amplification Assay With Lateral Flow Dipstick Assay for Rapid Detection of 2019 Novel Coronavirus. Zheng YZ; Chen JT; Li J; Wu XJ; Wen JZ; Liu XZ; Lin LY; Liang XY; Huang HY; Zha GC; Yang PK; Li LJ; Zhong TY; Liu L; Cheng WJ; Song XN; Lin M Front Cell Infect Microbiol; 2021; 11():613304. PubMed ID: 33598439 [TBL] [Abstract][Full Text] [Related]